N. Brünner

858 total citations
26 papers, 717 citations indexed

About

N. Brünner is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, N. Brünner has authored 26 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 14 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in N. Brünner's work include Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (7 papers) and Genetic factors in colorectal cancer (3 papers). N. Brünner is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (7 papers) and Genetic factors in colorectal cancer (3 papers). N. Brünner collaborates with scholars based in Denmark, Netherlands and China. N. Brünner's co-authors include Ross W. Stephens, Hans Jørgen Nielsen, Mads Holten-Andersen, I. J. Christensen, P. Oxholm, Henning Locht, Ole Slot, Gillian Murphy, William G. Stetler‐Stevenson and Keld Danø and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

N. Brünner

24 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Brünner Denmark 10 344 306 274 123 121 26 717
M Baillet United Kingdom 7 376 1.1× 585 1.9× 254 0.9× 92 0.7× 41 0.3× 10 906
Brandon McMahon United States 10 204 0.6× 128 0.4× 295 1.1× 86 0.7× 186 1.5× 32 675
Sara Junquera Spain 15 491 1.4× 502 1.6× 261 1.0× 98 0.8× 25 0.2× 21 841
Michael Bromberg United States 17 159 0.5× 140 0.5× 275 1.0× 85 0.7× 438 3.6× 27 930
Masanobu Kusano Japan 15 293 0.9× 334 1.1× 897 3.3× 119 1.0× 57 0.5× 28 1.2k
E. Wunder France 11 202 0.6× 306 1.0× 147 0.5× 121 1.0× 332 2.7× 28 696
Alice M. Walsh United States 13 180 0.5× 344 1.1× 301 1.1× 200 1.6× 64 0.5× 24 878
Cristina Rabascio Italy 17 243 0.7× 556 1.8× 476 1.7× 306 2.5× 272 2.2× 33 1.1k
J Delobel France 8 125 0.4× 318 1.0× 166 0.6× 196 1.6× 305 2.5× 17 708
Fabienne Hermitte France 11 357 1.0× 550 1.8× 433 1.6× 114 0.9× 310 2.6× 32 1.1k

Countries citing papers authored by N. Brünner

Since Specialization
Citations

This map shows the geographic impact of N. Brünner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Brünner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Brünner more than expected).

Fields of papers citing papers by N. Brünner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Brünner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Brünner. The network helps show where N. Brünner may publish in the future.

Co-authorship network of co-authors of N. Brünner

This figure shows the co-authorship network connecting the top 25 collaborators of N. Brünner. A scholar is included among the top collaborators of N. Brünner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Brünner. N. Brünner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brünner, N.. (2024). PARADE: Celebrating Community in Action. 10(1). 109–112. 1 indexed citations
2.
Guil‐Luna, Silvia, Jan Stenvang, N. Brünner, et al.. (2013). Progesterone Receptor Isoform Analysis by Quantitative Real-Time Polymerase Chain Reaction in Formalin-Fixed, Paraffin-Embedded Canine Mammary Dysplasias and Tumors. Veterinary Pathology. 51(5). 895–902. 3 indexed citations
3.
Stenvang, Jan, Marcel Smid, Søren Drud-Heydary Nielsen, et al.. (2012). Abstract P3-06-32: Topoisomerase 1 gene copy aberration is a frequent finding in clinical breast cancer samples. Cancer Research. 72(24_Supplement). P3–6. 2 indexed citations
4.
Duffy, Michael J., Rudolf Napieralski, John W.M. Martens, et al.. (2009). Methylated genes as new cancer biomarkers. European Journal of Cancer. 45(3). 335–346. 85 indexed citations
5.
Würtz, Sidse Ørnbjerg, Marie Klintman, M Fernö, et al.. (2009). Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer.. Cancer Research. 69(2_Supplement). 6057–6057. 1 indexed citations
6.
Holten-Andersen, Lars, Siri Beier Jensen, Allan Bardow, et al.. (2008). Identifying sources and estimating glandular output of salivary TIMP‐1. Scandinavian Journal of Clinical and Laboratory Investigation. 68(7). 548–554. 6 indexed citations
7.
Usher, P.A., Anieta M. Sieuwerts, Ulrik Lademann, et al.. (2007). Identification of alternatively spliced TIMP‐1 mRNA in cancer cell lines and colon cancer tissue. Molecular Oncology. 1(2). 205–215. 15 indexed citations
8.
Ghamande, Sharad, Michael Silverman, Michael A. Gold, et al.. (2007). A phase II randomized, double-blind, placebo-controlled trial of clinical activity and safety of Å6 in patients with asymptomatic CA 125 progression of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Journal of Clinical Oncology. 25(18_suppl). 16014–16014. 1 indexed citations
9.
10.
11.
Würtz, Sidse Ørnbjerg, et al.. (2007). High serum TIMP-1 correlates with poor prognosis in breast carcinoma – A validation study. Cancer Biomarkers. 3(6). 293–300. 14 indexed citations
12.
Holten-Andersen, Mads, I. J. Christensen, Mef Nilbert, et al.. (2003). Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival. European Journal of Cancer. 40(1). 64–72. 46 indexed citations
13.
Guo, Na, Anna M. Wu, Stefano Giannini, et al.. (2003). Combined Effects of Tamoxifen and a Chimeric Humanized Single Chain Antibody against the Type I IGF Receptor on Breast Tumor GrowthIn vivo. Hormone and Metabolic Research. 35(11/12). 836–842. 33 indexed citations
14.
Nielsen, Hans Jørgen, Ib Jarle Christensen, Mads Nordahl Svendsen, et al.. (2002). Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis. Inflammation Research. 51(11). 563–567. 63 indexed citations
15.
Slot, Ole, N. Brünner, Henning Locht, P. Oxholm, & Ross W. Stephens. (1999). Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Annals of the Rheumatic Diseases. 58(8). 488–492. 114 indexed citations
16.
Sier, Cornelis F.M., Ross W. Stephens, Jozef Bízik, et al.. (1998). The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients.. PubMed. 58(9). 1843–9. 156 indexed citations
17.
Holst‐Hansen, Claus, et al.. (1998). A new immunocapture assay for Escherichia coli beta-galactosidase for in vivo studies of lacZ-transduced tumor cells.. PubMed. 78(12). 1643–4. 4 indexed citations
18.
Grøndahl-Hansen, J, N. Brünner, Gary M. Clark, et al.. (1994). Urokinase-type receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies. Fibrinolysis and Proteolysis. 8. 123–123. 8 indexed citations
19.
Brünner, N., G. Bastert, Hans Skovgaard Poulsen, et al.. (1985). Characterization of the T61 human breast carcinoma established in nude mice. European Journal of Cancer and Clinical Oncology. 21(7). 833–843. 21 indexed citations
20.
Brünner, N., Mogens Spang‐Thomsen, Lars L. Vindeløv, A. Nielsen, & Svend A. Engelholm. (1984). Detection of Endocrine Responsiveness by Flow Cytometric DNA Analysis in Experimental Human Breast Cancer. Recent results in cancer research. 90. 200–204. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Baillet Breakdown of academic impact, for papers by Brandon McMahon Breakdown of academic impact, for papers by Sara Junquera Breakdown of academic impact, for papers by Michael Bromberg Breakdown of academic impact, for papers by Masanobu Kusano Breakdown of academic impact, for papers by E. Wunder Breakdown of academic impact, for papers by Alice M. Walsh Breakdown of academic impact, for papers by Cristina Rabascio Breakdown of academic impact, for papers by J Delobel Breakdown of academic impact, for papers by Fabienne Hermitte
Rankless by CCL
2026